Emerging options for the management of scorpion stings

Drug Design, Development and Therapy

Volumn 6, Issue , 2012, Pages 165-173

  Chippaux, Jean Philippe ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Antivenom; Envenoming; Scorpion; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALACRAMYN; ANALGESIC AGENT; ANASCORP; ANTIARRHYTHMIC AGENT; ANTISERUM; ATROPINE; BENZODIAZEPINE DERIVATIVE; CAPTOPRIL; CLONIDINE; CODEINE; DIAZEPAM; DIURETIC AGENT; DOBUTAMINE; HYDRALAZINE; LIDOCAINE; MIDAZOLAM; MORPHINE; NEUROTOXIN; NEUROTRANSMITTER; NIFEDIPINE; PLACEBO; PRAZOSIN; SALICYLIC ACID DERIVATIVE; SCORPIFAV; SCORPION VENOM; SCORPION VENOM ANTISERUM; TRAMADOL; UNCLASSIFIED DRUG; IMMUNOGLOBULIN FRAGMENT; VENOM ANTISERUM;

ADJUVANT THERAPY; ADRENERGIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BITES AND STINGS; BRADYCARDIA; CARDIOVASCULAR FUNCTION; CHEMICAL COMPOSITION; CLINICAL FEATURE; COMPLETE HEART BLOCK; CONVULSION; DEATH; DISEASE SEVERITY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; EARLY INTERVENTION; ENVENOMATION; HEART ARRHYTHMIA; HEART FAILURE; HEART RATE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNOTHERAPY; INFLAMMATION; ISCHEMIA; MUSCLE CRAMP; NEUROMUSCULAR DISEASE; NEUROMUSCULAR FUNCTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PAIN; PALLIATIVE THERAPY; PLASMA RENIN ACTIVITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; RESPIRATORY FUNCTION; RISK BENEFIT ANALYSIS; SCORPION STING; SIDE EFFECT; SWEAT GLAND DISEASE; TOXIN ANALYSIS; TREATMENT RESPONSE; TREMOR; UNSPECIFIED SIDE EFFECT; URINE RETENTION; ADULT; ANIMAL; CHILD; DRUG ANTAGONISM; HOSPITALIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW; SCORPION; TIME;

ADULT; ANIMALS; ANTIVENINS; BITES AND STINGS; CHILD; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTHERAPY; INFLAMMATION; NEUROTOXINS; SCORPION VENOMS; SCORPIONS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84867903466     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S24754     Document Type: Article

References (56)

1. Chippaux J P, Goyffon M. Epidemiology of scorpionism: a global appraisal. Acta Trop. 2008;107(2):71-79.
2. Celis A, Gaxiola-Robles R, Sevilla-Godinez E, de Orozco Valerio MJ, Armas J. Trends in mortality from scorpion stings in Mexico, 1979-2003. Rev Panam Salud Publica. 2007;21(6):373-380. Spanish.
3. Goyffon M, Vachon M, Broglio N. Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia. Toxicon. 1982;20(1):337-344.
4. Soulaymani R, Faraj Z, Semlali I. Epidemiological aspects of scorpion stings in Morocco. Rev Epidemiol Santé Publ. 2002;50(4):341-347. French.
5. Soulaymani Bencheikh R, Faraj Z, Semlali I, Ouammi L, Badri M. National strategy in the battle against scorpion stings and envenomations. Application and evaluation. Bull Soc Pathol Exot. 2003;96(4):317-319. French.
6. Soulaymani Bencheikh R, Idrissi M, Tamim O, et al. Scorpion stings in one province of Morocco: epidemiological, clinical and prognosis aspects. J Venom Anim Toxins Incl Trop Dis. 2007;13(2):462-471.
7. Chippaux J P. Estimating the global burden of snakebite can help to improve management. PLoS Med. 2008;5(11):e221.
8. Tan PT, Veeramani A, Srinivasan KN, Ranganathan S, Brusic V. SCORPION2: a database for structure-function analysis of scorpion toxins. Toxicon. 2006;47(3):356-363.
9. Bosmans F, Tytgat J. Voltage-gated sodium channel modulation by scorpion a-toxins. Toxicon. 2007;49(2):142-158.
10. +-channels. Eur J Biochem. 1999;264(2):287-300.
11. + channels and related peptides: biodiversity, structure-function relationships and evolution. Toxicon. 2005;46(8):831-844.
12. Meves H, Simard JM, Watt DD. Interactions of scorpion toxins with the sodium channel. Ann N Y Acad Sci. 1986;479(1):113-132.
13. Rodríguez de la Vega C, Possani LD. Novel paradigms on scorpion toxins that affect the activating mechanism of sodium channels. Toxicon. 2007;49(2):171-180.
14. + channel toxins from Tityus serrulatus venom on rat arterial blood pressure and plasma catecholamines. Comp Biochem Physiol C Pharmacol Toxicol. 2005;141(1):85-92.
15. +-channels. Toxicon. 2004;43(8):865-875.
16. Freire-Maia L, Campos JA. Pathophysiology and treatment of scorpion poisoning. In: Ownby CL, Odell G V, editors. Natural Toxins, Characterization, Pharmacology and Therapeutics. Proceedings of the 9th World Congress on Animal, Plant and Microbial Toxins. Oxford, UK: Pergamon Press; 1989.
17. Freire-Maia L, Campos JA, Amaral CF. Approaches to the treatment of scorpion envenoming. Toxicon. 1994;32(9):1009-1014.
18. Ismail M. The scorpion envenoming syndrome. Toxicon. 1995;33(7): 825-858.
19. Bahloul M, Ben Hamida C, Chtourou K, et al. Evidence of myocardial ischaemia in severe scorpion envenoming. Myocardial perfusion scintigraphy study. Intensive Care Med. 2004;30(3):461-467.
20. Benvenuti LA, Douetts K V, Cardoso JLC. Myocardial necrosis after envenoming by the scorpion Tityus serrulatus. Trans R Soc Trop Hyg. 2002;96(3):275-276.
21. Daisley H, Alexander D, Pitt-Miller P. Acute myocarditis following Tityus trinitatis envenoming: morphological and pathophysiological characteristics. Toxicon. 1999;37(1):159-165.
22. Bahloul M, Chaari A, Dammak H, et al. Pulmonary edema following scorpion envenoming: Mechanisms, clinical manifestations, diagnosis and treatment. Int J Cardiol. 2012;158(2):292-293.
23. Sofer S, Gueron M, White R, Lifshitz M, Apte R. Interleukin-6 release following scorpion sting in children. Toxicon. 1996;34(3): 389-392.
24. Magalhães MM, Pereira ME, Amaral CFS, et al. Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting. Toxicon. 1999;37(8):1155-1164.
25. Meki AR, Mohey El-Dean ZM. Serum interleukin-1β, interleukin-6, nitric oxide and a1-antitripsin in scorpion envenomed children. Toxicon. 1998;36(12):1851-1859.
26. D'Suze G, Moncada S, González C, Sevcik C, Aguilar V, Alagón A. Relationship between plasmatic levels of various cytokines, tumour necrosis factor, enzymes, glucose and venom concentration following Tityus scorpion sting. Toxicon. 2003;41(3):367-375.
27. Abdel-Haleem AA, Meki AMA, Noaman HA, Mohamed ZT. Serum levels of IL-6 and its soluble receptor, TNF-α and chemokine RANTES in scorpion envenomed children: their relation to scorpion envenomation outcome. Toxicon. 2006;47(4):437-444.
28. Adi-Bessalem S, Hammoudi-Triki D, Laraba-Djebari F. Pathophysiological effects of Androctonus australis hector scorpion venom: tissue damages and infammatory response. Exp Toxicol Pathol. 2008;60(4-5):373-380.
29. Petricevich VL. Scorpion venom and the infammatory response. Mediators Infamm. 2010;903295.
30. Jalali A, Pipelzadeh MH, Taraz M, Khodadadi A, Makvandi M, Rowan EG. Serum TNF-α levels reflect the clinical severity of envenomation following a Hemiscorpius lepturus sting. Eur Cytokine Netw. 2011;22(1):5-10.
31. de Sousa Alves R, do Nascimento NR, Barbosa PS, et al. Renal effects and vascular reactivity induced by Tityus serrulatus venom. Toxicon. 2005;46(3):271-276.
32. Gmar-Bouraoui S, Ben Dhia N, Frih A, Skhiri H, Achour A, el May M. Scorpion sting and acute interstitial nephropathy: Apropos of 1 case. Méd Trop. 2000;60(3):305-306.
33. Jain MK, Indurkar M, Kastwar V, Malviya S. Myocarditis and multiple cerebral and cerebellar infarction following scorpion sting. J Assoc Physicians India. 2006;54(6):491-492.
34. Romero NO, Hernández TJM. Cerebral edema associated to scorpion sting: a two-case sting report. J Venom Anim Toxins Incl Trop Dis. 2005;11(4):594-600.
35. Thacker AK, Lal R, Misra M. Scorpion bite and multiple cerebral infarcts. Neurol India. 2002;50(1):100-102.
36. Khattabi A, Soulaymani-Bencheikh R, Achour S, Salmi LR; for the Scorpion Consensus Expert Group. Classifcation of clinical consequences of scorpion stings: consensus development. Trans R Soc Trop Med Hyg. 2011;105(7):364-369.
37. Arrowsmith JB, Kennedy DL, Kuritsky JN, Faich GA. National patterns of aspirin use and Reye syndrome reporting, United States, 1980 to 1985. Pediatrics. 1987;79(6):858-863.
38. Hall SM, Plaster PA, Glasgow JF, Hancock P. Preadmission antipyretics in Reye's syndrome. Arch Dis Child. 1988;63(7):857-866.
39. Ismail M. The treatment of the scorpion envenoming syndrome: the Saudi experience with serotherapy. Toxicon. 1994;32(9): 1019-1026.
40. Nascimento EB Jr, Costa KA, Bertollo CM, et al. Pharmacological investigation of the nociceptive response and edema induced by venom of the scorpion Tityus serrulatus. Toxicon. 2005;45(5):585-593.
41. Bawaskar HS, Bawaskar PH. Severe envenoming by the Indian red scorpion Mesobuthus tamulus: the use of prazosin therapy. QJM. 1996;89(9):701-704.
42. Bawaskar HS, Bawaskar PH. Vasodilators: scorpion envenoming and the heart (an Indian experience). Toxicon. 1994;32(9):1031-1040.
43. Krishnan A, Sonawane RV, Karnad DR. Captopril in the treatment of cardiovascular manifestations of Indian red scorpion (Mesobuthus tamulus concanesis Pocock) envenoming. J Assoc Physicans India. 2007;55(1):22-26.
44. Gupta BD, Parakh M, Purohit A. Management of scorpion sting: prazosin or dobutamine. J Trop Pediatr. 2010;56(2):115-118.
45. Gibly R, Williams M, Walter FG, McNally J, Conroy C, Berg RA. Continuous intravenous midazolam infusion for Centruroides exilicauda scorpion envenoming. Ann Emerg Med. 1999;34(5):620-625.
46. Boyer LV, Theodorou AA, Berg RA, et al; Arizona Envenomation Investigators. Antivenom for critically ill children with neurotoxicity from scorpion stings. N Engl J Med. 2009;360(20):2090-2098.
47. Bawaskar HS, Bawaskar PH. Role of atropine in management of cardiovascular manifestations of scorpion envenoming in humans. J Trop Med Hyg. 1992;95(1):30-35.
48. Seifert SA. Atropine use in Centruroides scorpion envenoming - contraindicated or not? J Toxicol Clin Toxicol. 2001;39(6):599-600.
49. Chippaux J P, Goyffon M. Venoms, antivenoms and immunotherapy. Toxicon. 1998;36(6):823-846.
50. Ghalim N, El-Hafny B, Sebti F, et al. Scorpion envenoming and serotherapy in Morocco. Am J Trop Med Hyg. 2000;62(2):277-283.
51. Hammoudi-Triki D, Ferquel E, Robbe-Vincent A, Bon C, Choumet V, Laraba-Djebari F. Epidemiological data, clinical admission gradation and biological quantifcation by ELISA of scorpion envenomings in Algeria: effect of immunotherapy. Trans R Soc Trop Med Hyg. 2004;98(4):240-250.
52. Sevcik C, D'Suze G, Díaz P et al. Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab')2 extrusion mechanism from blood to tissues. Toxicon. 2004;44(7):731-741.
53. Abroug F, Elatrous S, Nouira S, Haguiga H, Touzi N, Bouchoucha S. Serotherapy in scorpion envenomation: a randomised controlled trial. Lancet. 1999;354(9182):906-909.
54. Bawaskar HS, Bawaskar PH. Utility of scorpion antivenin vs prazosin in the management of severe Mesobuthus tamulus (Indian red scorpion) envenoming at rural setting. J Assoc Physicians India. 2007;55(1):14-21.
55. Chippaux J P, Stock R P, Massougbodji A. Methodology of clinical studies dealing with the treatment of envenoming. Toxicon. 2010;55(7):1195-1212.
56. Bawaskar HS, Bawaskar PH. Effcacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial. Br Med J. 2011;342:c7136.